Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05703672 · ClinicalTrials.gov registry record · Phase 3
Switching to E-cigarettes in Smokers Not Interested in Quitting
A Phase 3 study of Smoking Reduction, sponsored by University of Kansas Medical Center.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 500
- Enrollment target
- 2
- Study locations
NCT05703672 is a Phase 3 study of Smoking Reduction that is actively recruiting participants, run by University of Kansas Medical Center. The registered enrollment target is 500 participants, above the 238-participant average among 10 other Smoking Reduction trials with a reported enrollment target (110% higher). The trial reports 2 study locations across 1 state.
The verdict
NCT05703672, a Phase 3 study of Smoking Reduction, is actively recruiting participants, sponsored by University of Kansas Medical Center.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 500 participants
- Enrollment target
- 2
- Study locations
Study Summary
The objectives of this application are to 1) compare short- and long-term harm reduction and abuse liability potential of a nicotine salt pod-based electronic cigarettes (EC) in adult (AA) exclusive EC, dual cig-EC, and exclusive cig users, 2) characterize factors that predict who switches fully, partially, or not at all, and 3) examine if harm reduction can be further enhanced by treating dual users with varenicline (VAR) to eliminate cigarette smoking.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Varenicline Tartrate
- OTHER Electronic cigarette
Study Locations (2)
Missouri
- Swope Health Central - Kansas City
- University of Kansas Medical Center - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2023-07-17 |
| Est. Completion | 2027-02-28 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05703672
The ClinicalTrials.gov registry entry for NCT05703672 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 238-participant average among 10 other Smoking Reduction trials with a reported enrollment target (110% higher). The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Smoking Reduction appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT05703672 reports 2 study locations spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT05703672 about?
NCT05703672 is a clinical study titled "Switching to E-cigarettes in Smokers Not Interested in Quitting". The objectives of this application are to 1) compare short- and long-term harm reduction and abuse liability potential of a nicotine salt pod-based electronic cigarettes (EC) in adult (AA) exclusive EC, dual cig-EC, and exclusive cig users, 2) characterize factors that predict who switches fully, pa...
What is the current status of trial NCT05703672?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 500 participants. The study started on 2023-07-17. Estimated completion is 2027-02-28.
What conditions does trial NCT05703672 study?
This clinical trial studies the following conditions: Smoking Reduction.
What interventions are being tested in trial NCT05703672?
The interventions under investigation include: Placebo (DRUG), Varenicline Tartrate (DRUG), Electronic cigarette (OTHER).
Who is sponsoring clinical trial NCT05703672?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05703672 being conducted?
This trial has 2 study locations across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Reduction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children
RECRUITING · Phase 4
-
The Impact of Menthol Flavoring on Switching in Adult Menthol Smokers
RECRUITING · NA
-
Leveraging Community Pharmacists to Optimize Smoking Cessation Services for Rural Smokers in Appalachia
RECRUITING · NA
-
Trauma-Informed Care for Smoking Cessation for Pregnancy
RECRUITING · NA
-
A Study Evaluating the Use of an Indoor Air Quality Monitor to Promote a Smoke-free Home
RECRUITING · NA
-
rTMS-concurrent Behavioral Priming for Reducing Smoking Cravings
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.